Search

Your search keyword '"Neurocysticercosis"' showing total 40 results

Search Constraints

Start Over You searched for: Descriptor "Neurocysticercosis" Remove constraint Descriptor: "Neurocysticercosis" Region mexico Remove constraint Region: mexico
40 results on '"Neurocysticercosis"'

Search Results

1. Neurocysticercosis: The duration of its preclinical phase relies on the parasite location.

2. Taenia solium: Socioeconomic changes and prevalence evolution in four endemic communities in northwestern Mexico.

Catalog

Books, media, physical & digital resources

3. Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries.

4. Natural history of extraparenchymal neurocysticercosis.

5. A novel, sequencing-free strategy for the functional characterization of Taenia solium proteomic fingerprint.

6. CUANTIFICACIÓN DE CITOCINAS PRO Y ANTIINFLAMATORIAS EN EL LÍQUIDO CEFALORRAQUÍDEO DE PACIENTES CON NEUROCISTICERCOSIS.

7. NEUROCISTICERCOSIS: NUEVAS EVIDENCIAS SOBRE LA HETEROGENEIDAD DE SU FASE PRECLÍNICA.

8. Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico.

9. Spinal Taenia solium cysticercosis in Mexican and Indian patients: a comparison of 30-year experience in two neurological referral centers and review of literature.

10. New-onset Geriatric Epilepsy in a Latin American Country: A Multi-centric Study from Mexico.

11. Cost of neurocysticercosis patients treated in two referral hospitals in Mexico City, Mexico.

12. Colocación de derivación ventrículo peritoneal en pacientes con neurocisticercosis: descripción de la situación actual en el INNN.

13. Estudio bibliométrico de la Neurocisticercosis: comparativo de la producción científica de Brasil y El Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez.

14. Neurocysticercosis is still prevalent in Mexico.

15. Incidencia y presentación clínica de la neurocisticercosis en el Hospital Universitario José Eleuterio González.

16. Estimating the Non-Monetary Burden of Neurocysticercosis in Mexico.

17. Neurocysticercosis May No Longer Be a Public Health Problem in Mexico.

18. Neurocysticercosis: risk and primary prevention strategies update.

20. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors

21. Evaluation of recombinant glutathione transferase 26 kDa, thioredoxin-1, and endophilin B1 of Taenia solium in the diagnosis of human neurocysticercosis.

22. Estudio comparativo de pacientes con Epilepsia y Neurocisticercosis, con y sin Esclerosis Mesial Temporal.

23. Epilepsia farmacorresistente asociada a Neurocisticercosis calcificada en una población de pacientes del INNNMVS.

24. Cirugía de epilepsia en pacientes con epilepsia fármacorresistente y Neurocisticercosis calcificada: experiencia en el Instituto Nacional de Neurología y Neurocirugía "Dr. Manuel Velasco Suárez".

25. Evolución de los anticuerpos anti Taenia solium en pacientes con neurocisticercosis.

26. Evaluacion del perfil de citocinas periféricas asociado con la respuesta al tratamiento en la neurocisticercosis extraparenquimatosa: un estudio longitudinal.

27. Neurocisticercosis en México. ¿Un problema de salud pública persistente o en vías de extinción?

28. An epidemiological study of familial neurocysticercosis in an endemic Mexican community

29. Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper.

31. Epilepsy: A bibliometric analysis (1968–2020) of the Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez" in Mexico.

32. Neurocysticercosis, a Persisting Health Problem in Mexico.

33. Corticosteroids, Central Serous Chorioretinopathy, and Neurocysticercosis.

34. Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35-55 in cerebral spinal fluid.

35. Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis.

37. Serological diagnosis and follow-up of severe neurocysticercosis using HP10 antigen detection.

38. Neurocisticercosis y VIH-1, 25 años de seguimiento de una epidemia conjunta.

40. Ventricular Obstruction From Neurocysticercosis.